Literature DB >> 2873143

Reaction pathway of bovine aortic lysyl oxidase.

P R Williamson, H M Kagan.   

Abstract

The catalysis of amine oxidation by lysyl oxidase has been probed to assess for the likely order of substrate binding and product release and to discriminate between mechanistic alternatives previously proposed for other copper-dependent amine oxidases using molecular oxygen as a substrate. Lineweaver-Burk plots revealed a pattern of parallel lines when the oxidation of n-butylamine was followed at different fixed concentrations of oxygen consistent with a "ping-pong" kinetic mechanism in which the aldehyde is produced and released before the binding of oxygen, the second substrate. Initial burst experiments revealed the ability of lysyl oxidase to form and release n-butyraldehyde in amounts stoichiometric with functional active site content in the absence of oxygen, consistent with the ping-pong kinetics obtained. Reciprocal plots of n-butylamine oxidation in the presence of fixed concentrations of the reaction products were consistent with a Uni Uni Uni Bi ping-pong kinetic mechanism with the aldehyde being the first, H2O2 the second, and ammonia the last departing product. Moreover, spectral studies of the oxidation of p-hydroxybenzylamine by lysyl oxidase indicated that the enzyme does not process the amine substrate to a noncovalently bound p-hydroxybenzaldimine intermediate subsequently to be hydrolyzed to p-hydroxybenzaldehyde. The kinetic mechanism of lysyl oxidase thus appears to be similar to those described for diamine oxidase and pig plasma monoamine oxidase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873143

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  PQQ and quinoproteins: an important novel field in enzymology.

Authors:  J A Duine
Journal:  Antonie Van Leeuwenhoek       Date:  1989-05       Impact factor: 2.271

2.  LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells.

Authors:  J P Cebrià-Costa; L Pascual-Reguant; A Gonzalez-Perez; G Serra-Bardenys; J Querol; M Cosín; G Verde; R A Cigliano; W Sanseverino; S Segura-Bayona; A Iturbide; D Andreu; P Nuciforo; C Bernado-Morales; V Rodilla; J Arribas; J Yelamos; A Garcia de Herreros; T H Stracker; S Peiró
Journal:  Oncogene       Date:  2019-08-28       Impact factor: 9.867

3.  Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor.

Authors:  Hector M Rodriguez; Maria Vaysberg; Amanda Mikels; Scott McCauley; Arleene C Velayo; Carlos Garcia; Victoria Smith
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

4.  Purification, properties and influence of dietary copper on accumulation and functional activity of lysyl oxidase in rat skin.

Authors:  N Romero-Chapman; J Lee; D Tinker; J Y Uriu-Hare; C L Keen; R R Rucker
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

5.  LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing LOXL2-induced epithelial-mesenchymal transition (EMT).

Authors:  Ting Peng; Shitong Lin; Yifan Meng; Peipei Gao; Ping Wu; Wenhua Zhi; Wencheng Ding; Canhui Cao; Peng Wu
Journal:  Cell Cycle       Date:  2022-05-11       Impact factor: 5.173

6.  Steady-state kinetic analysis of the quinoprotein methylamine dehydrogenase from Paracoccus denitrificans.

Authors:  V L Davidson
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

Review 7.  Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

Authors:  Philip C Trackman
Journal:  Expert Opin Ther Targets       Date:  2016-03-03       Impact factor: 6.902

8.  Increased serum lysyl oxidase-like 2 levels correlate with the degree of left atrial fibrosis in patients with atrial fibrillation.

Authors:  Yingming Zhao; Kangting Tang; Xu Tianbao; Junhong Wang; Jin Yang; Dianfu Li
Journal:  Biosci Rep       Date:  2017-11-21       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.